Yusaku Shirai

Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats

Kosuke Kaji, Hitoshi Yoshiji, Yasuhide Ikenaka et al. · Journal of Gastroenterology · 2013 · 130 citations

Liver Fibrosis, Pathology, Hepatic Fibrosis +16

Losartan, an angiotensin-II type 1 receptor blocker, attenuates the liver fibrosis development of non-alcoholic steatohepatitis in the rat

Hitoshi Yoshiji, Ryuichi Noguchi, Yasuhide Ikenaka et al. · BMC Research Notes · 2009 · 57 citations · Full text

Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats

Kosuke Kaji, Hitoshi Yoshiji, Mitsuteru Kitade et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 2011 · 54 citations

Iron Metabolism, Pathology, Pharmacotherapy +20

Cross talk between toll‐like receptor‐4 signaling and angiotensin‐II in liver fibrosis development in the rat model of non‐alcoholic steatohepatitis

Yusaku Shirai, Hitoshi Yoshiji, Ryuichi Noguchi et al. · Journal of Gastroenterology and Hepatology · 2013 · 47 citations

Crosstalk between angiogenesis, cytokeratin-18, and insulinresistance in the progression of non-alcoholic steatohepatitis

Mitsuteru Kitade, Hitoshi Yoshiji, Ryuichi Noguchi et al. · World Journal of Gastroenterology · 2009 · 41 citations · Full text